1.
Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009
by DeFronzo, R. A
Diabetologia, 2010-04-02, Vol.53 (7), p.1270-1287
2.
Native incretins prevent the development of atherosclerotic lesions in apolipoprotein E knockout mice
by Nagashima, M
Diabetologia, 2011-07-24, Vol.54 (10), p.2649-2659
3.
TNF-related apoptosis-inducing ligand (TRAIL) protects against diabetes and atherosclerosis in Apoe−/− mice
by Di Bartolo, B. A
Diabetologia, 2011-10-01, Vol.54 (12), p.3157-3167
4.
Sitagliptin reduces plaque macrophage content and stabilises arteriosclerotic lesions in Apoe−/− mice
by Vittone, F
Diabetologia, 2012-05-18, Vol.55 (8), p.2267-2275
5.
A reappraisal of the role of circulating (progenitor) cells in the pathobiology of diabetic complications
by Fadini, G. P
Diabetologia, 2013-10-31, Vol.57 (1), p.4-15
6.
Delayed intervention with AGE inhibitors attenuates the progression of diabetes-accelerated atherosclerosis in diabetic apolipoprotein E knockout mice
by Watson, A. M. D
Diabetologia, 2010-12-14, Vol.54 (3), p.681-689
7.
Age at menarche and risk of type 2 diabetes among African-American and white women in the Atherosclerosis Risk in Communities (ARIC) study
by Dreyfus, J. G
Diabetologia, 2012-07-04, Vol.55 (9), p.2371-2380
8.
Impact of macrophage toll-like receptor 4 deficiency on macrophage infiltration into adipose tissue and the artery wall in mice
by Coenen, K. R
Diabetologia, 2008-12-04, Vol.52 (2), p.318-328
9.
Elevated resistin levels induce central leptin resistance and increased atherosclerotic progression in mice
by Asterholm, Ingrid W
Diabetologia, 2014-03-13, Vol.57 (6), p.1209-1218
10.
Fetuin-A influences vascular cell growth and production of proinflammatory and angiogenic proteins by human perivascular fat cells
by Siegel-Axel, Dorothea I
Diabetologia, 2014-02-04, Vol.57 (5), p.1057-1066
11.
Calcium and phosphate concentrations and future development of type 2 diabetes: the Insulin Resistance Atherosclerosis Study
by Lorenzo, Carlos
Diabetologia, 2014-04-26, Vol.57 (7), p.1366-1374
12.
Pharmacological inhibition of NOX reduces atherosclerotic lesions, vascular ROS and immune-inflammatory responses in diabetic Apoe (-/-) mice
by Di Marco, E
Diabetologia, 2014-03, Vol.57 (3), p.633-642
13.
The metabolic syndrome : time for a critical appraisal joint statement from the American Diabetes Association and the European Association for the Study of Diabetes
by KAHN, R
Diabetologia, 2005, Vol.48 (9), p.1684-1699
14.
Differential white cell count and incident type 2 diabetes: the Insulin Resistance Atherosclerosis Study
by Lorenzo, Carlos
Diabetologia, 2013-10-19, Vol.57 (1), p.83-92
15.
Urotensin II receptor antagonism confers vasoprotective effects in diabetes associated atherosclerosis: studies in humans and in a mouse model of diabetes
by Watson, A. M. D
Diabetologia, 2013-01-24, Vol.56 (5), p.1155-1165
16.
Common carotid intima-media thickness does not add to Framingham risk score in individuals with diabetes mellitus: the USE-IMT initiative
by Ruijter, H.M. Den
Diabetologia, 2013, Vol.56 (7), p.1494-1502
17.
Extracellular PBEF/NAMPT/visfatin activates pro-inflammatory signalling in human vascular smooth muscle cells through nicotinamide phosphoribosyltransferase activity
by Romacho, T
Diabetologia, 2009-08-29, Vol.52 (11), p.2455-2463
18.
Reactive oxygen species mediate high glucose-induced heparanase-1 production and heparan sulphate proteoglycan degradation in human and rat endothelial cells: a potential role in t...
by Rao, G
Diabetologia, 2011, Vol.54 (6), p.1527-1538
19.
Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes : a comparison of patients treated with sulfonylureas and metformin
by EVANS, J. M. M
Diabetologia, 2006, Vol.49 (5), p.930-936
20.
The endothelin receptor antagonist avosentan ameliorates nephropathy and atherosclerosis in diabetic apolipoprotein E knockout mice
by Watson, A. M. D
Diabetologia, 2009-10-28, Vol.53 (1), p.192-203
